TIME Selects Viz.ai CEO Dr. Chris Mansi in TIME100 AI List of the World's Most Influential People in Artificial Intelligence

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, is pleased to announce that its CEO and co-founder, Dr. Chris Mansi, has been named an Innovator on the prestigious 2024 TIME100 AI list, an honor that recognizes the world’s 100 most influential people advancing and shaping artificial intelligence (AI).

“It is an incredible honor to be included on the TIME100 AI list alongside such diverse and future-driven thinkers, but it is also a reflection of the collective efforts of our team at Viz.ai,” said Dr. Chris Mansi. “Since we started Viz.ai, we’ve been dedicated to advancing healthcare systems to work smarter and faster, and ultimately improve patient outcomes through artificial intelligence. We will continue to revolutionize the way patient care is delivered.”

As a trained neurosurgeon, Dr. Mansi is familiar with the challenges patients face in accessing treatments when they are needed. Inspired by a patient who underwent a successful brain surgery and yet died because the surgery came too late, Dr. Mansi founded Viz.ai in 2016 with a goal of using artificial intelligence to accelerate care coordination and reduce systemic delays that stand between patients and life-saving treatments.

“Chris's unwavering commitment to increasing patient access to life-saving treatments is deserving of this recognition,” said Mamoon Hamid, Partner, Kleiner Perkins. “The significance of the Viz.ai team's impact cannot be overstated. They are getting patients to the right diagnosis, specialist, and treatment faster, ensuring that they don’t get lost in our complex healthcare system.”

With two de Novo clearances by the Food and Drug Administration (FDA) since 2018 and more than 50,000 providers today across 1700 hospitals on the end-to-end platform, Viz.ai continues to lead transformation in healthcare and life sciences and provide real-world impacts for patients.

The TIME100 AI list is an annual global recognition that features remarkable leaders, scientists, policymakers, and entrepreneurs across various fields who are shaping today's AI landscape. To assemble the list, TIME's editors and reporters solicited nominations and recommendations from industry leaders and dozens of expert sources. The TIME100 AI list will be featured in the September 16, 2024 issue of TIME, available on newsstands beginning Friday, September 6.

About Viz.ai, Inc.

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,700 hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai One^TM is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.